Amanda Allmaras
Family · Bismarck, NDNPI 1184063000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- Lilly USA, LLC$569
- Amgen$465
- Pfizer$429
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$351
- Astellas Pharma US Inc$248
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,03398%
- Education$1242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $844 |
| Lilly USA, LLC | 40 | $569 |
| Amgen | 28 | $465 |
| Pfizer | 29 | $429 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $351 |
| Astellas Pharma US Inc | 9 | $248 |
| Novartis | 12 | $206 |
| Boehringer Ingelheim | 12 | $194 |
| Lundbeck LLC | 11 | $182 |
| Sanofi-aventis U.S. LLC | 10 | $176 |
| Novo Nordisk | 10 | $153 |
| Bayer | 9 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $147 |
| Amarin Pharma, Inc. | 7 | $136 |
| Merck | 9 | $136 |
| AstraZeneca | 7 | $98 |
| Medicure Pharma Inc. | 2 | $92 |
| E.r. Squibb & Sons, L.L.C. | 5 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $68 |
| Mayne Pharma Commercial LLC | 1 | $65 |
| Eisai Inc. | 3 | $61 |
| Idorsia Pharmaceuticals US Inc | 4 | $58 |
| Kowa Pharmaceuticals America, Inc. | 4 | $54 |
| Upsher-smith Laboratories LLC | 2 | $41 |
| Radius Health, Inc. | 2 | $34 |
| Myovant Sciences Inc. | 2 | $31 |
| GSK | 2 | $29 |
| IBSA Pharma Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
How this compares
$5,157 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 15 | $420 |
Paid to pharmacies, not to this prescriber.
Other family in Bismarck
- Courtney WoodburyBismarck$8K
- Monica GoetzBismarck$8K
- Elizabeth ScheurerBismarck$6K
- Kayla HolzerBismarck$5K
- Kathryn StensgardBismarck$5K
- Sally FrankBismarck$4K
- Amy GotvasleeBismarck$4K
- Michelle MaierBismarck$4K
- Tanya GuthmillerBismarck$4K
- Amanda HelmBismarck$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.